Related references
Note: Only part of the references are listed.Preparation of Alum-borneol-PVP Drug-loaded Fibers by Electrospinning
Libing Huang et al.
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES (2021)
Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy
Xiang Xiong et al.
NANO TODAY (2021)
Multistage Adaptive Nanoparticle Overcomes Biological Barriers for Effective Chemotherapy
Ying Wang et al.
SMALL (2021)
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
Clement Anfray et al.
CELLS (2020)
Molecular dynamics study on the encapsulation and release of anti-cancer drug doxorubicin by chitosan
Jiachen Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Multifunctional Nanomodulators Regulate Multiple Pathways To Enhance Antitumor Immunity
Yadan Zheng et al.
ACS APPLIED BIO MATERIALS (2020)
Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy
Ya-Ru Zhang et al.
SMALL (2020)
Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy
Linhua Zhang et al.
NANO LETTERS (2019)
Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway
Zi Yin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Macrophage-Mediated Subversion of Anti-Tumour Immunity
Valeria Quaranta et al.
CELLS (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Lillian Sun et al.
JCI INSIGHT (2019)
Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate.
Robin Rajan et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer
Nicholas Borcherding et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy
Xuejiao Song et al.
NANO RESEARCH (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Chayanon Ngambenjawong et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
CSF-1R-Dependent Lethal Hepatotoxicity When Agonistic CD40 Antibody Is Given before but Not after Chemotherapy
Katelyn T. Byrne et al.
JOURNAL OF IMMUNOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery
Ran Mo et al.
MATERIALS TODAY (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi et al.
LANCET ONCOLOGY (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Targeting C-type lectin receptors for cancer immunity
Huimin Yan et al.
FRONTIERS IN IMMUNOLOGY (2015)
Advances in Combination Therapies Based on Nanoparticles for Efficacious Cancer Treatment: An Analytical Report
Serge Mignani et al.
BIOMACROMOLECULES (2015)
Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy
Xiudan Zhan et al.
BIOMATERIALS (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
The development of site-specific drug delivery nanocarriers based on receptor mediation
Xueqing Wang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
A monosaccharide-modified peptide phage library for screening of ligands to carbohydrate-binding proteins
Kanako Arai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Targeting of Tumor-Associated Macrophages Made Possible by PEG-Sheddable, Mannose-Modified Nanoparticles
Saijie Zhu et al.
MOLECULAR PHARMACEUTICS (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
Michael Platten et al.
CANCER RESEARCH (2012)
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
Massimo Zollo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Differing Patterns of Circulating Regulatory T Cells and Myeloid-derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF With Peptide Vaccination
Ahmad A. Tarhini et al.
JOURNAL OF IMMUNOTHERAPY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Synthesis, characterization and cellular internalization of poly(2-hydroxyethyl methacrylate) bearing α-D-mannopyranose
Makoto Obata et al.
POLYMER CHEMISTRY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Ultralow-Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications
Shaoyi Jiang et al.
ADVANCED MATERIALS (2010)
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Andrew L. Doedens et al.
CANCER RESEARCH (2010)
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Kiavash Movahedi et al.
CANCER RESEARCH (2010)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
Silvina Gazzaniga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
A carbohydrate-antioxidant hybrid polymer reduces oxidative damage in spermatozoa and enhances fertility
C Fleming et al.
NATURE CHEMICAL BIOLOGY (2005)
Alizarin Red S. as a general optical reporter for studying the binding of boronic acids with carbohydrates
G Springsteen et al.
CHEMICAL COMMUNICATIONS (2001)
Share Paper
